NeurOptics is the leader in the science of pupillometry. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technology for use in critical care medicine, neurology, neurosurgery, emergency medicine, and research. The NeurOptics NPi-200 Pupillometer has been adopted in over 325 trauma and stroke centers in the United States. Headquartered in Laguna Hills, Calif., NeurOptics is represented in more than 24 countries worldwide.